Position in IMCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,756,718
-$209,388 QoQ
Shares Held
323,606
+12.7% QoQ
Ownership
0.636%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 96.13666001248433.ToString("F0")%
Shared 0.ToString("F0")%
None 3.863339987515683.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. IMCR ranks #134 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in IMCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,756,718 | 323,606 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,966,106 | 287,125 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $9,780,179 | 269,204 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,464,640 | 237,879 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $5,158,454 | 173,861 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,853,907 | 130,641 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $12,602,200 | 404,825 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $29,445,797 | 868,864 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $52,082,810 | 801,274 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $62,653,741 | 917,063 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $49,880,465 | 961,088 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $48,724,812 | 812,622 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $39,378,513 | 796,491 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,243,983 | 354,722 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,029,263 | 149,750 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $871,075 | 23,347 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $70,324 | 2,352 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $48,107 | 1,405 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $86,038 | 2,321 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $781 | 20 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $647,361 | 15,207 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||